Fellowship · Charlottesville, VA
Sponsored by University of Virginia Medical Center
Stroke genetics informs drug discovery and risk prediction across ancestries.
Nature · 2022 · 477 citations · Bradford Worrall
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
The Lancet. Neurology · 2024 · 95 citations · Kelly Gwathmey
Risk Factors Associated With Mortality and Neurologic Disability After Intracerebral Hemorrhage in a Racially and Ethnically Diverse Cohort.
JAMA network open · 2022 · 87 citations · Bradford Worrall
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial.
Nature medicine · 2026 · 14 citations · Kelly Gwathmey
Diagnostic delay in amyotrophic lateral sclerosis.
European journal of neurology · 2023 · 53 citations · Kelly Gwathmey
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
JAMA · 2025 · 22 citations · Matthew Elliott
Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseases.
Expert review of clinical immunology · 2025 · 21 citations · Kelly Gwathmey
Outcome after acute ischemic stroke is linked to sex-specific lesion patterns.
Nature communications · 2021 · 85 citations · Bradford Worrall